Retatrutide
01Retatrutide is the most advanced metabolic compound of its generation. It acts simultaneously on three receptors: it suppresses appetite (GLP-1), optimizes insulin sensitivity and energy use (GIP), and activates hepatic thermogenesis to burn fat (Glucagon). In Phase 2 clinical trials (NEJM, 2023), participants achieved reductions of up to 24.2% in body weight over 48 weeks — the greatest reduction documented for a single agent.
| Route | Subcutaneous, once weekly |
| Escalation | 0.5 mg → 1.0 → 2.0 → 4.0 → 6.0–8.0 mg (every 2 weeks) |
| Range | 1–12 mg/week |
| Reconstitution | 1 ml BAC per 10 mg vial = 10 mg/ml |
| Duration | 12–24 weeks with escalation and gradual taper |
| Precautions | Increase dose slowly, prioritize protein, stay well hydrated |
Tirzepatide
02Tirzepatide revolutionized the field by demonstrating that the combined activation of GLP-1 and GIP produces results superior to any single agonist. In the SURMOUNT-1 trial (NEJM, 2022), it achieved reductions of up to 22.5% in body weight. It offers better glycemic control, less metabolic fatigue, and greater energy efficiency than semaglutide.
| Route | Subcutaneous, once weekly |
| Escalation | 2.5 mg → 5.0 → 7.5 → 10.0 mg (every 4 weeks) |
| Range | 2.5–15 mg/week |
| Reconstitution | 1 ml BAC per 10 mg vial = 10 mg/ml |
| Duration | 12–24+ weeks |
| Precautions | Escalate gradually, prioritize protein, stay hydrated |
GHK-Cu
03GHK-Cu is a natural tripeptide (Glycine-Histidine-Lysine bound to copper) discovered in human plasma in the 1970s. Its levels decline with age, and reintroducing it activates cellular repair processes, collagen and elastin synthesis, and improvements in hair health. It is one of the most studied peptides in anti-aging and dermal regeneration.
| Route | Subcutaneous, topical, or microneedling |
| SC Dose | 1–2 mg daily |
| Reconstitution | 1–2 ml BAC per 50 mg vial |
| Duration | 4–8 weeks, cyclic |
| Compatibility | Avoid combination with topical zinc (Cu-Zn antagonism) |
| Precautions | Moderate doses, cycle use, do not use continuously without a break |
NAD+
04NAD+ is a fundamental coenzyme present in all living cells, essential for cellular energy production (ATP), DNA repair, and the activation of sirtuins (longevity proteins). Its levels decline significantly with age, and replenishment is associated with improvements in energy, cognitive function, and markers of aging.
| Route | Subcutaneous or intravenous (IV) |
| SC Dose | 50–200 mg according to protocol |
| Frequency | 1–3 times per week |
| Duration | 4–12 weeks, cyclic |
| Precautions | May cause flushing (redness); start with low doses |
TB-500 + BPC-157 Blend
05A higher-concentration version of the TB-500 + BPC-157 repair blend, designed for longer protocols or injuries that require greater coverage. The same local + systemic repair synergy, with greater yield per vial and less frequent reconstitution.
| Route | Subcutaneous (local or abdominal) |
| Dose | 250–500 mcg of each component, once daily |
| Reconstitution | 2 ml BAC per 20 mg vial (10+10) |
| Duration | 6–8 weeks, then a 2–4 week break |
| Precautions | Rotate injection sites, use aseptic technique |
IGF-1 LR3
06IGF-1 LR3 is a modified version of insulin-like growth factor with an extended half-life. It directly promotes hyperplasia (the creation of new muscle cells) and hypertrophy. It is one of the most powerful compounds for tissue growth, recovery, and advanced body composition.
| Route | Subcutaneous or intramuscular |
| Dose | 20–80 mcg/day (split pre/post workout) |
| Reconstitution | 1 ml BAC per 1 mg vial = 1000 mcg/ml |
| Duration | 4–6 weeks maximum, mandatory break |
| Precautions | Monitor glucose, do not use continuously, keep cycles short |
GHRP-6
07GHRP-6 is a growth hormone secretagogue that stimulates the pituitary through activation of the ghrelin receptor. In addition to raising GH, it produces a marked increase in appetite, making it ideal for bulking phases or for people who struggle to eat enough.
| Route | Subcutaneous |
| Dose | 100–300 mcg per application, 1–3 times per day |
| Timing | Fasted, before sleep, or post-workout |
| Duration | 8–12 weeks, then a 4-week break |
| Precautions | Avoid carbohydrates/sugar 30 min before and after |
Ipamorelin
08Ipamorelin is the cleanest and most selective GH secretagogue available. Unlike GHRP-6, it does not significantly raise cortisol or prolactin, which makes it ideal for long-term protocols. It stimulates GH in a natural, pulsatile way, improving sleep, recovery, and body composition without adverse hormonal effects.
| Route | Subcutaneous |
| Dose | 100–300 mcg, 1–2 times per day |
| Timing | Before sleep (key) and/or fasted |
| Duration | 8–16 weeks |
| Precautions | Avoid sugar before applying; do not combine with meals |
BPC-157
09BPC-157 is a fragment of a natural gastric protein with one of the most extensive preclinical evidence bases in peptide research. It accelerates healing, improves local blood flow, protects nerves, and reduces inflammation. Its versatility makes it useful for everything from sports injuries to intestinal repair.
| Route | Subcutaneous (local to the affected area) |
| Dose | 250–500 mcg daily |
| Reconstitution | 1 ml BAC per 2 mg vial = 2000 mcg/ml |
| Duration | 2–4 weeks, pause and repeat |
| Precautions | Moderate dose, stay hydrated, do not prolong without breaks |
Epithalon
10Epithalon (Epitalon) is a tetrapeptide developed in Russia focused on activating telomerase, the enzyme that protects telomeres and regulates cellular aging. It also optimizes circadian rhythm, melatonin production, and age-related hormonal functions. It is not cosmetic: it is deep aging biology.
| Route | Subcutaneous |
| Dose | 5–10 mg daily |
| Duration | 10–20 days, 1–2 times per year |
| Reconstitution | 1–2 ml BAC per 10 mg vial |
| Precautions | Short cycles only, no continuous use, sleep well during protocol |
CJC-1295 No DAC
11CJC-1295 without DAC (also called Mod GRF 1-29) is an optimized version of natural GHRH that generates physiological pulses of growth hormone. Because it has a short half-life, it mimics the natural pulses of GH without saturating receptors or producing constant stimulation. It is the ideal complement to Ipamorelin.
| Route | Subcutaneous |
| Dose | 100–150 mcg per application, 1–3 times per day |
| Timing | Before sleep (key), fasted, post-workout |
| Duration | 8–16 weeks |
| Precautions | Avoid sugar before applying; do not saturate receptors |
Tesamorelin
12Tesamorelin is the only GH-stimulating peptide with formal clinical approval. It was specifically approved for the reduction of visceral (deep abdominal) fat associated with HIV lipodystrophy. Additional studies in adults without HIV show significant improvements in insulin sensitivity and metabolic profile.
| Route | Subcutaneous |
| Dose | 2 mg daily |
| Timing | Before sleep |
| Duration | 12–26 weeks |
| Precautions | Monitor glucose and IGF-1; monitor sodium |
MOTS-c
13MOTS-c is a peptide derived from mitochondrial DNA that regulates mitochondria-to-nucleus communication. It is called an 'exercise mimetic' because it partially reproduces the metabolic effects of exercise: it improves insulin sensitivity, activates AMPK, and optimizes energy metabolism.
| Route | Subcutaneous |
| Dose | 5 mg per injection, 3–5 times per week |
| Timing | Morning or pre-physical activity |
| Duration | 4–8 weeks |
| Precautions | Avoid combining with metformin without supervision |
Selank
14Selank was developed in Russia in the 1990s as a safe alternative to benzodiazepines: no addiction, no tolerance, no sedation, no cognitive impairment. It is a synthetic analog of tuftsin (an immune system peptide), optimized to act in the brain. It returns you to an optimal state of mental functioning.
| Route | Intranasal (primary) or subcutaneous |
| Nasal Dose | 250–300 mcg, 1–2 times per day |
| SC Dose | 250–500 mcg, once daily |
| Duration | 10–14 days, then a 1–2 week break |
| Precautions | Morning or early day; avoid night if it activates mental clarity |
Semax
15Semax is a synthetic heptapeptide analogous to the ACTH 4-10 fragment, with no real hormonal activity. Developed in Russia to treat ischemic brain damage, it is now used for its powerful nootropic effects: it improves memory, learning, and attention. It entered the Russian Federation's List of Vital Medicines in 2011.
| Route | Intranasal (primary) or subcutaneous |
| Nasal Dose | 250–1000 mcg, 1–3 times per day |
| SC Dose | 300–600 mcg, once daily |
| Duration | 10–14 intensive days or 2–4 cognitive weeks |
| Precautions | Morning only; avoid night (may cause insomnia) |
GLOW Blend
16GLOW is a triple blend that combines three regenerative peptides: BPC-157 for local tissue repair, TB-500 for systemic regeneration, and GHK-Cu for cellular rejuvenation, collagen support, and dermal health. It is the all-in-one protocol for recovery, aesthetics, and anti-aging in a single solution.
| Route | Subcutaneous (also compatible with microneedling for GHK-Cu) |
| Dose | According to the blend ratio, 0.3–0.5 ml daily |
| Reconstitution | 2–3 ml BAC per 70 mg vial |
| Duration | 6–8 weeks, then a 2–4 week break |
| Precautions | Avoid topical zinc with GHK-Cu, rotate sites, use aseptic technique |
Important Notice
This catalog is for educational purposes only. It does not constitute medical advice or a therapeutic recommendation of any kind. The use of research compounds should be carried out under medical supervision.